Annual ROE
-671.99%
-587.35%-693.94%
31 December 2023
Summary:
Hepion Pharmaceuticals annual return on equity is currently -671.99%, with the most recent change of -587.35% (-693.94%) on 31 December 2023. During the last 3 years, it has fallen by -621.76% (-1237.83%). HEPA annual ROE is now -473.24% below its all-time high of 180.04%, reached on 30 June 2014.HEPA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-505.74%
-177.08%-53.88%
30 September 2024
Summary:
Hepion Pharmaceuticals quarterly return on equity is currently -505.74%, with the most recent change of -177.08% (-53.88%) on 30 September 2024. Over the past year, it has dropped by -367.78% (-266.58%). HEPA quarterly ROE is now -115.06% below its all-time high of 3359.13%, reached on 31 December 2014.HEPA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HEPA ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -693.9% | -266.6% |
| 3 y3 years | -1237.8% | -1580.2% |
| 5 y5 years | -40.5% | -530.3% |
HEPA ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1809.6% | at low | -1580.2% | at low |
| 5 y | 5 years | -1809.6% | at low | -1580.2% | at low |
| alltime | all time | -473.2% | +47.9% | -115.1% | +78.2% |
Hepion Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -505.74%(+53.9%) |
| June 2024 | - | -328.66%(+22.3%) |
| Mar 2024 | - | -268.74%(+19.4%) |
| Dec 2023 | -671.99%(+693.9%) | -225.04%(+63.1%) |
| Sept 2023 | - | -137.96%(+39.5%) |
| June 2023 | - | -98.93%(+8.8%) |
| Mar 2023 | - | -90.89%(+41.6%) |
| Dec 2022 | -84.64%(+140.5%) | -64.17%(+8.9%) |
| Sept 2022 | - | -58.93%(+12.4%) |
| June 2022 | - | -52.44%(+53.4%) |
| Mar 2022 | - | -34.19%(+10.8%) |
| Dec 2021 | -35.19%(-29.9%) | -30.87%(+2.6%) |
| Sept 2021 | - | -30.10%(-14.9%) |
| June 2021 | - | -35.38%(-24.6%) |
| Mar 2021 | - | -46.90%(-47.9%) |
| Dec 2020 | -50.23%(+11.5%) | -90.01%(-16.2%) |
| Sept 2020 | - | -107.47%(+40.2%) |
| June 2020 | - | -76.63%(+41.7%) |
| Mar 2020 | - | -54.08%(-2.9%) |
| Dec 2019 | -45.06% | -55.72%(-30.6%) |
| Sept 2019 | - | -80.24%(-11.5%) |
| June 2019 | - | -90.65%(-83.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -536.07%(+26.6%) |
| Dec 2018 | -478.42%(+135.9%) | -423.28%(+42.7%) |
| Sept 2018 | - | -296.64%(-42.3%) |
| June 2018 | - | -513.94%(+356.8%) |
| Mar 2018 | - | -112.52%(-65.3%) |
| Dec 2017 | -202.83%(+23.4%) | - |
| Sept 2017 | - | -324.38%(-37.1%) |
| June 2017 | -164.40%(-87.3%) | -515.52%(-77.8%) |
| Mar 2017 | - | -2322.80%(+73.0%) |
| Dec 2016 | - | -1342.86%(-9.0%) |
| Sept 2016 | - | -1475.33%(+35.3%) |
| June 2016 | -1290.12%(+209.2%) | -1090.32%(+32.7%) |
| Mar 2016 | - | -821.64%(+74.0%) |
| Dec 2015 | - | -472.30%(+23.7%) |
| Sept 2015 | - | -381.82%(+36.2%) |
| June 2015 | -417.20%(-331.7%) | -280.41%(+115.2%) |
| Mar 2015 | - | -130.31%(-103.9%) |
| Dec 2014 | - | 3359.13%(+1207.2%) |
| Sept 2014 | - | 256.97%(+34.9%) |
| June 2014 | 180.04% | 190.51%(-46.4%) |
| Mar 2014 | - | 355.45%(+312.2%) |
| Dec 2013 | - | 86.23%(+52.8%) |
| Sept 2013 | - | 56.45% |
FAQ
- What is Hepion Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual ROE year-on-year change?
- What is Hepion Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly ROE year-on-year change?
What is Hepion Pharmaceuticals annual return on equity?
The current annual ROE of HEPA is -671.99%
What is the all time high annual ROE for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual return on equity is 180.04%
What is Hepion Pharmaceuticals annual ROE year-on-year change?
Over the past year, HEPA annual return on equity has changed by -587.35% (-693.94%)
What is Hepion Pharmaceuticals quarterly return on equity?
The current quarterly ROE of HEPA is -505.74%
What is the all time high quarterly ROE for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly return on equity is 3359.13%
What is Hepion Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, HEPA quarterly return on equity has changed by -367.78% (-266.58%)